Consistency of the “central vein sign” in chronic multiple sclerosis lesions
Background - In recent years, there has been an increasing interest in the central vein sign (CVS) as a new imaging marker and previous cross-sectional studies demonstrated that the CVS has the potential to discriminate multiple sclerosis (MS) lesions from non-MS lesions. The aim of this study was t...
Saved in:
| Main Authors: | , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
February 2022
|
| In: |
Multiple Sclerosis and Related Disorders
Year: 2022, Volume: 58, Pages: 1-4 |
| ISSN: | 2211-0356 |
| DOI: | 10.1016/j.msard.2022.103530 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1016/j.msard.2022.103530 Verlag, lizenzpflichtig, Volltext: https://www.sciencedirect.com/science/article/pii/S2211034822000451 |
| Author Notes: | Matthias Reichl, Matthias Wittayer, Claudia E. Weber, Michael Platten, Achim Gass, Philipp Eisele |
| Summary: | Background - In recent years, there has been an increasing interest in the central vein sign (CVS) as a new imaging marker and previous cross-sectional studies demonstrated that the CVS has the potential to discriminate multiple sclerosis (MS) lesions from non-MS lesions. The aim of this study was to investigate the consistency of the CVS in a longitudinal magnetic resonance imaging (MRI) data set. - Methods - 3T MRI datasets from seventy-one people with MS acquired at baseline and after 12 months-follow-up were analyzed. Chronic lesions were identified on fluid-attenuated inversion recovery (FLAIR) images. Co-registered susceptibility-weighted/FLAIR images were analyzed for the presence of a CVS at baseline and follow-up. - Results - A total of 183 chronic lesions were included in the final analysis. At baseline MRI, a CVS was detectable in 141/183 (77%) lesions. Overall, the CVS was consistent in 114/141 (81%) lesions (Cohen's kappa = 0.46, standard error = 0.07). - Conclusion - The CVS is a rather stable feature in chronic MS lesions and therefore represents a robust imaging marker that could increase the specificity of MRI in MS. |
|---|---|
| Item Description: | Online verfügbar: 15. Januar 2022, Artikelversion: 21. Januar 2022 Im Titel ist “central vein sign” in Anführungszeichen geschrieben Gesehen am 14.05.2024 |
| Physical Description: | Online Resource |
| ISSN: | 2211-0356 |
| DOI: | 10.1016/j.msard.2022.103530 |